Photo Gallery



News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  • WJPPS Impact Factor
  • Its our Pleasure to Inform you that WJPPS Impact Factor has been increased from  7.454 to 7.632  due to high quality Publication at International Level

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • SEPTEMBER 2021 Issue has been successfully launched on 1 September 2021.



Fakhsheena Anjum*, Nighat Razvi, Wajiha Iffat


Breast cancer is reported having highest prevalence in Pakistan in Asia. It is treated with adjuvant radiotherapy after surgery with or without chemotherapy and later with endocrine therapy to get better overall survival rate. This study was conducted to perceive the effects of radiation and hormonal therapies in female breast cancer patients in Karachi, Pakistan. The cross sectional study was conducted from April 2011 to January 2012, n=811 patients were registered in KIRAN hospital, Karachi, Pakistan. The data collected through patients’ interview and their medical profiles were assessed statistically using the version 16.0 of SPSS. Out of n=811 female patients, majority were suffering from stage I or II of breast cancer. Most of the patients (97.16%) received radiation therapy whereas hormonal therapy was given to 62.63% patients, majority belonging to age group of 41-50 years. The patients may have previously received adjuvant chemotherapy and/or radiation therapy. Overall response for radiation therapy was good in 90.86% and partial in 8.88% breast cancer patients. The most common adverse reactions observed after radiation therapies were fatigue (75.88%) and skin hyperpigmentation (72.08%). The overall response observed during the follow ups for hormonal therapy was good in all patients. The most common adverse reactions observed due to hormonal therapy within 3-6 months were heat intolerance (50.98%) and myalgia (40.55%). 55.70% patients were at risk for developing cardiovascular diseases due to their existing comorbidities while having hormonal therapy. The treatment modalities should be selected according to patients’ forbearance and disease stage. Adverse effects arising from these treatments must be managed timely so as to have patients’ compliance and improvement in their quality of life.

Keywords: Breast cancer, hormonal therapy, letrozole, radiation therapy, tamoxifen.

[Full Text Article]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More